Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2000
06/29/2000WO2000037094A2 Therapeutic applications of flint polypeptides
06/29/2000WO2000037093A1 Bone resorption inhibitors
06/29/2000WO2000037085A1 Treatment of diseases involving cyst formation
06/29/2000WO2000037075A1 Combination of an at1 angiotensin ii receptor antagonist and an immunosuppressant
06/29/2000WO2000037067A2 Sensitizing agents for the treatment of skin lesions
06/29/2000WO2000037053A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
06/29/2000WO2000037052A1 Pulmonary drug delivery
06/29/2000WO2000037051A1 Aerosol formulations for buccal and pulmonary application
06/29/2000WO2000037022A2 Combination therapy for the treatment of sepsis
06/29/2000WO2000036927A1 Method for producing granulates containing enzymes
06/29/2000WO2000036920A1 Polynucleotide and polypeptide sequences of rabbit g-protein alpha 16
06/29/2000WO2000036919A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
06/29/2000WO2000036918A1 Methods and compositions for treatment of cell proliferative disorders
06/29/2000WO2000036910A1 Msh5 ablated mice and uses therefor
06/29/2000WO2000018907A3 Antisense-sequences for inhibiting the expression of the adhesion molecule icam-1
06/29/2000WO2000012726A3 Rationally designed heparinases derived from heparinase i and ii
06/29/2000WO2000012683A3 Stem cells bearing an fgf receptor on the cell surface
06/29/2000WO2000012542A3 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
06/29/2000WO2000012506A3 Collections of compounds
06/29/2000WO2000012118A3 Inhibiting cardiomyocyte death
06/29/2000WO2000012113A3 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
06/29/2000WO2000009073A3 Blood-brain barrier therapeutics
06/29/2000WO2000008155A3 Human receptor-associated proteins
06/29/2000WO2000008145A3 Novel genes in control of hematopoiesis
06/29/2000WO2000006605A3 Heterominibodies
06/29/2000WO2000001817A3 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods
06/29/2000WO2000000610A3 Human signal peptide-containing proteins
06/29/2000WO2000000594A3 Human transferases
06/29/2000WO1999066909A3 Method and compositions for the treatment or amelioration of female sexual dysfunction
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000WO1999062945A3 Peptide antigens for detection of hiv, hcv and other microbial infections
06/29/2000WO1999055854A3 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth
06/29/2000WO1999049019A3 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
06/29/2000WO1999003881A3 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
06/29/2000WO1998059034A3 Treponema pallidum polynucleotides and sequences
06/29/2000DE19954305A1 Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie Peptides of AT¶1¶ receptor and their use, in particular for pre-eclampsia Diagnostider
06/29/2000DE19860541A1 Composition for the treatment of vascular disease comprises holozyme with hyaluronate lyase activity from microbial origin
06/29/2000DE19859910A1 Cyclosporin-Lösung Cyclosporin solution
06/29/2000DE19859780A1 Mittel zur Inhibition der Gewebsneubildung Means for inhibiting the formation of tissue
06/29/2000DE19859385A1 Verfahren zur Herstellung von enzymhaltigen Granulaten A process for producing enzyme-containing granules
06/29/2000CA2450402A1 Methods and compositions for inhibiting cancer cell growth comprising pro224
06/29/2000CA2371289A1 Novel polypeptides and nucleic acids encoding same
06/29/2000CA2359586A1 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
06/29/2000CA2358508A1 Therapeutic applications of flint polypeptides
06/29/2000CA2358492A1 Combination therapy for the treatment of sepsis
06/29/2000CA2357413A1 Sensitizing agents for the treatment of skin lesions
06/29/2000CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
06/29/2000CA2356765A1 Bone resorption inhibitors
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2356244A1 Somatic cells with ablated prp gene and methods of use
06/29/2000CA2356010A1 Treatment of hepatitis c virus infections with interleukin-10
06/29/2000CA2355968A1 Novel protein and dna thereof
06/29/2000CA2355876A1 Chlamydia trachomatis antigens
06/29/2000CA2355874A1 .alpha.v.beta.6 integrin inhibitors
06/29/2000CA2355836A1 Genetic suppressor elements against human immunodeficiency virus
06/29/2000CA2355631A1 Msh5 ablated mice and uses therefor
06/29/2000CA2355630A1 Compounds useful in the treatment of inflammatory diseases
06/29/2000CA2355364A1 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
06/29/2000CA2355228A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
06/29/2000CA2355163A1 Three dimensional structure of a sterile alpha motif domain
06/29/2000CA2355074A1 Lymphocytic membrane proteins
06/29/2000CA2354846A1 Method of enhancing the biological activity of ligands
06/29/2000CA2354843A1 Outer surface proteins, their genes, and their use
06/29/2000CA2354536A1 Ribavirin-pegylated interferon alfa induction hcv combination therapy
06/29/2000CA2354369A1 Complementary dna's encoding proteins with signal peptides
06/29/2000CA2354074A1 Method of identifying a psychotropic agent using differential gene expression
06/29/2000CA2354030A1 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
06/29/2000CA2353848A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
06/29/2000CA2353799A1 Methods and compositions for inhibiting neoplastic cell growth
06/29/2000CA2353790A1 Non-viral transfection vector
06/29/2000CA2353775A1 Compositions and methods for the treatment of tumor
06/29/2000CA2353635A1 Anilide derivative, production and use thereof
06/29/2000CA2352535A1 Method for preparing suspension of stable posiplexes
06/29/2000CA2346960A1 Diagnostic and therapeutics for sepsis
06/28/2000EP1013772A1 Method for preparing suspension of stable posiplexes
06/28/2000EP1013770A1 Non-viral transfection vector
06/28/2000EP1013764A1 Immunomodulators
06/28/2000EP1013763A1 CANINE INTERLEUKIN 18, CANINE INTERLEUKIN 1$g(b) CONVERTASE, DNA SEQUENCES ENCODING THE SAME, PROCESS FOR PRODUCING INTERLE UKIN 18, AND REMEDIES FOR CANINE IMMUNOLOGICAL DISEASES
06/28/2000EP1013762A2 Delta-like gene expressed in neuroendocrine tumors
06/28/2000EP1013761A2 Humanized chimeric antibody directed against ganglioside GD3
06/28/2000EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same
06/28/2000EP1013665A1 Novel polypeptide having water channel activity and dna sequence
06/28/2000EP1013664A1 Antigenic determinants for drug-specific T lymphocytes from drug-allergic patients
06/28/2000EP1013288A2 Erythropoietin in the treatment of domestic and livestock animals for anemia
06/28/2000EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
06/28/2000EP1013285A2 Urokinase-type plasminogen activator receptor
06/28/2000EP1013284A2 Purified forms of dnase
06/28/2000EP1013283A2 Pharmaceutical and foodstuff compositions containing transferrins and antibacteral agents for potentiating host defence activity and the treatment of infections
06/28/2000EP1013282A2 Pharmaceutical and foodstuff compositions containing transferrins and antibacteral agents for potentiating host defence activity and the treatment of infections
06/28/2000EP1013281A1 hCG therapy for the treatment of breast cancer
06/28/2000EP1013280A1 Skin preparations for external use
06/28/2000EP1013270A2 Controlled release growth hormone containing microspheres
06/28/2000EP1012603A1 Functional fragments of hiv-1 vpr protein and methods of using the same
06/28/2000EP1012347A1 Determination and control of bimolecular interactions
06/28/2000EP1012338A1 A tumor suppressor designated ts10q23.3
06/28/2000EP1012333A1 ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23
06/28/2000EP1012329A1 Diagnosis and treatment of myocardial failure
06/28/2000EP1012320A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/28/2000EP1012317A2 Hypoxia inducible promoter
06/28/2000EP1012313A1 INTRACELLULAR INHIBITORS OF Gq PROTEIN SIGNALING